Gene-variant specific effects of plasma amyloid-β levels in Swedish autosomal dominant Alzheimer disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Gene-variant specific effects of plasma amyloid-β levels in Swedish autosomal dominant Alzheimer disease ; volume:16 ; number:1 ; day:25 ; month:9 ; year:2024 ; pages:1-11 ; date:12.2024
Alzheimer's research & therapy ; 16, Heft 1 (25.9.2024), 1-11, 12.2024

Creator: Johansson, Charlotte
Thordardottir, Steinunn
Laffita-Mesa, José
Pannee, Josef
Rodriguez-Vieitez, Elena
Zetterberg, Henrik
Blennow, Kaj
Graff, Caroline

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13195-024-01574-w

URN: urn:nbn:de:101:1-2412112116203.756094821174

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Johansson, Charlotte
Thordardottir, Steinunn
Laffita-Mesa, José
Pannee, Josef
Rodriguez-Vieitez, Elena
Zetterberg, Henrik
Blennow, Kaj
Graff, Caroline
SpringerLink (Online service)

Other Objects (12)

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

Plasma Amyloid-β dynamics in late-life major depression: a longitudinal study

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress

Decreased levels of soluble amyloid β-protein precursor and β-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus

Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer’s disease with multi-modal PET and plasma GFAP

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism

Heteromers of amyloid precursor protein in cerebrospinal fluid

Origins of amyloid-β

Performance on a pattern separation task by Alzheimer’s patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levels

Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

Plasma Amyloid-β dynamics in late-life major depression: a longitudinal study

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress

Decreased levels of soluble amyloid β-protein precursor and β-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus

Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer’s disease with multi-modal PET and plasma GFAP

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism

Heteromers of amyloid precursor protein in cerebrospinal fluid

Origins of amyloid-β

Performance on a pattern separation task by Alzheimer’s patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levels

Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

Plasma Amyloid-β dynamics in late-life major depression: a longitudinal study

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress

Decreased levels of soluble amyloid β-protein precursor and β-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus

Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer’s disease with multi-modal PET and plasma GFAP

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism

Heteromers of amyloid precursor protein in cerebrospinal fluid

Origins of amyloid-β

Performance on a pattern separation task by Alzheimer’s patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levels

Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Gene-variant specific effects of plasma amyloid-β levels in Swedish autosomal dominant Alzheimer disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

Plasma Amyloid-β dynamics in late-life major depression: a longitudinal study

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress

Decreased levels of soluble amyloid β-protein precursor and β-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus

Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer’s disease with multi-modal PET and plasma GFAP

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism

Heteromers of amyloid precursor protein in cerebrospinal fluid

Origins of amyloid-β

Performance on a pattern separation task by Alzheimer’s patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levels

Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

Plasma Amyloid-β dynamics in late-life major depression: a longitudinal study

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress

Decreased levels of soluble amyloid β-protein precursor and β-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus

Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer’s disease with multi-modal PET and plasma GFAP

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism

Heteromers of amyloid precursor protein in cerebrospinal fluid

Origins of amyloid-β

Performance on a pattern separation task by Alzheimer’s patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levels

Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

Plasma Amyloid-β dynamics in late-life major depression: a longitudinal study

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress

Decreased levels of soluble amyloid β-protein precursor and β-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus

Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer’s disease with multi-modal PET and plasma GFAP

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism

Heteromers of amyloid precursor protein in cerebrospinal fluid

Origins of amyloid-β

Performance on a pattern separation task by Alzheimer’s patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levels

Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study

Related objects

Reset password